Literature DB >> 18678577

Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis.

M Neidhart1, X Baraliakos, C Seemayer, C Zelder, R E Gay, B A Michel, H Boehm, S Gay, J Braun.   

Abstract

BACKGROUND: Ankylosing spondylitis (AS) is a common, largely genetically determined, rheumatic disease that is characterised by spinal inflammation and new bone formation. However, the exact pathogenesis and pathology are still not clear.
OBJECTIVE: To analyse tissue obtained at spinal surgery by immunohistochemistry and compare the specimen of patients with AS to those with degenerative disc disease (DDD).
METHODS: Bony and soft tissue specimens of 30 patients with AS and 20 with DDD were obtained during spinal osteotomy from different anatomic regions including articular and spinous processes, interspinous ligaments and intervertebral disks. Immunohistolochemistry was performed with established markers for cathepsin K, matrix metalloproteinase (MMP)1, MMP3 and receptor activator for nuclear factor kappaB (RANK) ligand.
RESULTS: Cathepsin K and MMP1-positive cells were only observed in AS specimens. Cathepsin K-positive multinucleated cells were detected at articular processes adjacent to fibrous tissues. MMP1 was expressed in smaller mononuclear cells attached to bone. Invasion of bone by MMP1 cells was seen at entheseal sites. In the intervertebral disks, most mononuclear cells were cathepsin K-positive. Isolated cells expressing these matrix-degrading enzymes found in DDD never showed signs of invasion. No differences were found for MMP3 between AS and DDD. Clear expression of RANK ligand was only detected in one patient with AS.
CONCLUSIONS: Cathepsin K is strongly expressed in different regions of the spine in AS. Cathepsin K was mainly expressed by mononuclear cells, fibroblast-like cells and cells attached to bone and at sites of bone remodelling, suggestive of high osteoclastic activity. This supports the role of persistent inflammation in the pathogenesis of AS. How these changes relate to osteoproliferation remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18678577     DOI: 10.1136/ard.2008.092494

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Association between apparent diffusion coefficient and intervertebral disc degeneration in patients with ankylosing spondylitis.

Authors:  Mustafa Resorlu; Ferhat Gokmen; Hatice Resorlu; Gurhan Adam; Ayla Akbal; Sibel Cevizci; Abdullah Sariyildirim; Yilmaz Savas; Mustafa Guven; Adem Bozkurt Aras
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up.

Authors:  Helga Raquel Garcia Ferrer; Alexander Azan; Isa Iraheta; Joan Von Feldt; Luis R Espinoza; Julia Manasson; Jose U Scher; Abraham Garcia Kutzbach; Alexis Ogdie
Journal:  Clin Rheumatol       Date:  2017-11-14       Impact factor: 2.980

Review 3.  Pathogenesis of ankylosing spondylitis.

Authors:  Lai-Shan Tam; Jieruo Gu; David Yu
Journal:  Nat Rev Rheumatol       Date:  2010-06-01       Impact factor: 20.543

4.  Update on biologic therapy in the management of axial spondyloarthritis.

Authors:  Frank Heldmann; Friedrich Dybowski; Ertan Saracbasi-Zender; Claas Fendler; Jürgen Braun
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

Review 5.  Disease modification in ankylosing spondylitis.

Authors:  Walter P Maksymowych
Journal:  Nat Rev Rheumatol       Date:  2010-02       Impact factor: 20.543

Review 6.  [Management of axial spondyloarthritis].

Authors:  U Kiltz; X Baraliakos; J Braun
Journal:  Internist (Berl)       Date:  2016-11       Impact factor: 0.743

7.  HLA-B27 alters the response to tumor necrosis factor α and promotes osteoclastogenesis in bone marrow monocytes from HLA-B27-transgenic rats.

Authors:  Gerlinde Layh-Schmitt; Eva Y Yang; Grace Kwon; Robert A Colbert
Journal:  Arthritis Rheum       Date:  2013-08

8.  Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis.

Authors:  Katalin Gulyás; Ágnes Horváth; Edit Végh; Anita Pusztai; Ágnes Szentpétery; Zsófia Pethö; Andrea Váncsa; Nóra Bodnár; Péter Csomor; Attila Hamar; Levente Bodoki; Harjit Pal Bhattoa; Balázs Juhász; Zoltán Nagy; Katalin Hodosi; Tamás Karosi; Oliver FitzGerald; Gabriella Szücs; Zoltán Szekanecz; Szilvia Szamosi; Sándor Szántó
Journal:  Clin Rheumatol       Date:  2019-09-14       Impact factor: 2.980

9.  Circulating Levels of Soluble Receptor Activator of NF- κ B Ligand and Matrix Metalloproteinase 3 (and Their Antagonists) in Asian Indian Patients with Ankylosing Spondylitis.

Authors:  Varun Dhir; Rajni Srivastava; Amita Aggarwal
Journal:  Int J Rheumatol       Date:  2013-09-01

10.  Constitutive expression of cathepsin K in the human intervertebral disc: new insight into disc extracellular matrix remodeling via cathepsin K and receptor activator of nuclear factor-κB ligand.

Authors:  Helen E Gruber; Jane A Ingram; Gretchen L Hoelscher; Natalia Zinchenko; H James Norton; Edward N Hanley
Journal:  Arthritis Res Ther       Date:  2011-08-31       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.